Is GSK set to have a foothold in Dr Reddy's?
This article was originally published in Scrip
Executive Summary
There is speculation that GlaxoSmithKline is in talks with Dr Reddy's Laboratories to get a foothold in the Indian company – about 5% - with an additional first right of refusal should Dr Reddy's' founders want to divest or pare their holding.